➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Mallinckrodt
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

Litigation Details for Corephotonics, Ltd. v. Apple, Inc. (N.D. Cal. 2017)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Corephotonics, Ltd. v. Apple, Inc. (N.D. Cal. 2017)

Docket   Start Trial Date Filed 2017-11-06
Court District Court, N.D. California Date Terminated 2018-12-14
Cause 35:271 Patent Infringement Assigned To Lucy Haeran Koh
Jury Demand Plaintiff Referred To Nathanael M. Cousins
Parties APPLE, INC.; COREPHOTONICS, LTD.
Patents 10,004,700; 10,011,843; 10,017,712; 10,029,011; 10,029,015; 8,007,830; 8,022,106; 9,023,843
Attorneys Bahrad A. Sokhansanj; Benjamin T. Wang; Bruce Robert Zisser; Claude M. Stern; Heidi Lyn Keefe; James Shrin Tsuei; Lowell D. Mead; Marc Aaron Fenster; Neil Alan Rubin; Phillip Edward Morton; Priya Balakrishnan Viswanath; Stephen R. Smith; Yury Kapgan
Firms Cooley LLP; Phillip Edward Morton; Quinn Emanuel; Quinn Emanuel Urquhart and Sullivan LLP; Quinn Emanuel Urquhart Oliver & Hedges LLP; Russ August & Kabat
Link to Docket External link to docket
Small Molecule Drugs cited in Corephotonics, Ltd. v. Apple, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Corephotonics, Ltd. v. Apple, Inc.

Details for Corephotonics, Ltd. v. Apple, Inc. (N.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-05-22 109 Opposition/Response to Motion NW, Suite 700 Washington, DC 20004-2400 10 Telephone: …that were found patentable—including in one of the two patents on 4 which Corephotonics…proposes to proceed to trial. Meanwhile, all ten patents in the 19-cv-4809 5 case…20 Case No. 19-cv-4809, Dkt. 28 at 2-4. These related patents have serious invalidity defects as …despite having asserted 15 patents and threatened to assert 4 more, Corephotonics’s External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Harvard Business School
Express Scripts
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.